Biomedical Engineering Reference
In-Depth Information
obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996;
153:530-534.
114. Barker JNWN, Mitra RS, Griffiths CEM, Dixit VM, Nickoloff BJ. Keratino-
cytes as initiators of inflammation. Lancet 1991; 337:211-214.
115. Nickoloff BJ, Turka LA. Keratinocytes: key immunocytes of the integument.
Amer J Pathol 1993; 143:325-331.
116. Jordana M, Clancy R, Dolovich J, Denburg J. Effector role of the epithelial
compartment in inflammation. Ann N Y Acad Sci 1992; 664:180-189.
117. Mills PR, Davies RJ, Devalia JL. Airway epithelial cells, cytokines, and
pollutants. Am J Respir Crit Care Med 1999; 160:S38-S43.
118. Chung KF. Cytokines in chronic obstructive pulmonary disease. Eur Respir J
Suppl 2001; 34:50s-59s.
119. Koyama S, Rennard SI, Leikauf GD, et al. Endotoxin stimulates bronchial
epithelial cells to release chemotactic factors for neutrophils. J Immunol
1991; 147:4293-4301.
120. Leikauf GD, Driscoll KE, Wey HE. Ozone-induced augmentation of eicosa-
noid metabolism in epithelial cells from bovine trachea. Am Rev Respir Dis
1988; 137:435-442.
121. Raz M, Robbins RA, Kelling CL, et al. Viral infection of bovine bronchial
epithelial cells induces increased neutrophil chemotactic activity and neutro-
phil adhesion. Clin Sci 1993; 85:753-760.
122. Strieter RM. Interleukin-8: a very important chemokine of the human airway
epithelium. Am J Physiol Lung Cell Mol Physiol 2002; 283:L688-L689.
123. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1
=
interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 1989;
84:1045-1049.
124. Prause O, Laan M, Lotvall J, Linden A. Pharmacological modulation of inter-
leukin-17-induced GCP-2-, GRO-alpha and interleukin-8 release in human
bronchial epithelial cells. Eur J Pharmacol 2003; 462:193-198.
125. Kawaguchi M, Kokubu F, Matsukura S, et al. Induction of C-X-C chemo-
kines, growth-related oncogene alpha expression, and epithelial cell-derived
neutrophil-activating protein-78 by ML-1 (interleukin-17F) involves activa-
tion of Rafl-mitogen-activated protein kinase kinase-extracellular signal-regu-
lated kinase 1
=
2 pathway. J Pharmacol Exp Ther 2003; 307:1213-1220.
126. Strieter R, Kunkel S. Chemokines. In: Crystal R, West J, eds. The Lung: Scien-
tific Foundations. 2nd ed. Philadelphia: Lippincott-Raven, 1997:155-186.
127. Standiford TJ, Rolfe MW, Kunkel SL, et al. Macrophage inflammatory
protein-1
a
expression in interstitial lung disease. J Immunol 1993; 151:2852.
128. Wang JH, Devalia JL, Xia C, Sapsford RJ, Davies RJ. Expression of
RANTES by human bronchial epithelial cells in vitro and in vivo and the
effect of corticosteroids. Am J Respir Cell Mol Biol 1996; 14:27-35.
129. Fujisawa T, Kato Y, Atsuta J, et al. Chemokine production by the BEAS-2B
human bronchial epithelial cells: differential regulation of eotaxin, IL-8, and
RANTES by TH2-and TH1-derived cytokines. J Allergy Clin Immunol
2000; 105:126-133.
